Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$89.77
-$0.58 (-0.6%)
Closing price April 3, 2020
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Jon C. Ogg
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
Chris Lange
Monday's top analyst upgrades, downgrades and initiations included Alexion, American Water Works, Apple, Schwab, Crowdstrike, FedEx, IBM, Microsoft, Nvidia, Ryanair and Tesla.
Jon C. Ogg
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Chris Lange
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
Here are three Credit Suisse #1 Top Picks that are showing an implied upside of 50% or more for 2020 as of mid-December.
Jon C. Ogg
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in...
Chris Lange
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in...
Chris Lange
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Jon C. Ogg